OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

m6A mRNA methylation sustains Treg suppressive functions
Jiyu Tong, Guangchao Cao, Ting Zhang, et al.
Cell Research (2018) Vol. 28, Iss. 2, pp. 253-256
Open Access | Times Cited: 297

Showing 1-25 of 297 citing articles:

m6A modification controls the innate immune response to infection by targeting type I interferons
Roni Winkler, Ella Gillis, Lior Lasman, et al.
Nature Immunology (2018) Vol. 20, Iss. 2, pp. 173-182
Closed Access | Times Cited: 390

The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network
Maosheng Cheng, Sheng Lu, Qian Gao, et al.
Oncogene (2019) Vol. 38, Iss. 19, pp. 3667-3680
Open Access | Times Cited: 330

The RNA modification N6-methyladenosine as a novel regulator of the immune system
Ziv Shulman, Noam Stern‐Ginossar
Nature Immunology (2020) Vol. 21, Iss. 5, pp. 501-512
Closed Access | Times Cited: 330

The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis
Mengnuo Chen, Chun‐Ming Wong
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 267

A Review in Research Progress Concerning m6A Methylation and Immunoregulation
Caiyan Zhang, Jinrong Fu, Yufeng Zhou
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 242

Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer
Yi Chen, Lin Yu, Yongqian Shu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 220

RNA m6A modification and its function in diseases
Jiyu Tong, Richard A. Flavell, Huabing Li
Frontiers of Medicine (2018) Vol. 12, Iss. 4, pp. 481-489
Open Access | Times Cited: 203

Regulation of Gene Expression by N-methyladenosine in Cancer
Jun Liu, Bryan T. Harada, Chuan He
Trends in Cell Biology (2019) Vol. 29, Iss. 6, pp. 487-499
Open Access | Times Cited: 198

RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 194

The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 172

Pooled CRISPR screening identifies m 6 A as a positive regulator of macrophage activation
Jiyu Tong, Xuefei Wang, Yongbo Liu, et al.
Science Advances (2021) Vol. 7, Iss. 18
Open Access | Times Cited: 150

Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 149

The role of m6A modification in physiology and disease
Chuan Yang, Yiyang Hu, Bo Zhou, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 144

METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells
Hao Song, Jiaxi Song, Ming Cheng, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 143

Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 140

Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 140

m6A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development
Yimeng Gao, Radovan Vasic, Yuanbin Song, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 1007-1021.e8
Open Access | Times Cited: 139

m 6 A demethylase ALKBH5 controls CD4 + T cell pathogenicity and promotes autoimmunity
Jing Zhou, Xingli Zhang, Jiajia Hu, et al.
Science Advances (2021) Vol. 7, Iss. 25
Open Access | Times Cited: 138

The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity
Shoubao Ma, Jiazhuo Yan, Tasha Barr, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 8
Open Access | Times Cited: 135

NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation
Yuanbo Hu, Chenbin Chen, Xinya Tong, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 9
Open Access | Times Cited: 134

METTL3-dependent m6A modification programs T follicular helper cell differentiation
Yingpeng Yao, Ying Yang, Wenhui Guo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 133

Roles of RNA Methylation on Tumor Immunity and Clinical Implications
Maorun Zhang, Junmin Song, Weitang Yuan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 126

METTL3 overexpression aggravates LPS-induced cellular inflammation in mouse intestinal epithelial cells and DSS-induced IBD in mice
Lichao Yang, Guotao Wu, Qiang Wu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 69

m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56

Page 1 - Next Page

Scroll to top